MX2018015452A - Composiciones y metodos que modulan fosforo o las enzimas en un aminal de compañia. - Google Patents
Composiciones y metodos que modulan fosforo o las enzimas en un aminal de compañia.Info
- Publication number
- MX2018015452A MX2018015452A MX2018015452A MX2018015452A MX2018015452A MX 2018015452 A MX2018015452 A MX 2018015452A MX 2018015452 A MX2018015452 A MX 2018015452A MX 2018015452 A MX2018015452 A MX 2018015452A MX 2018015452 A MX2018015452 A MX 2018015452A
- Authority
- MX
- Mexico
- Prior art keywords
- phosphorus
- modulate
- enzymes
- companion animal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Un tipo específico de marcador de la salud de órganos en un animal de compañía puede mejorarse al ajustar la dieta del animal para aumentar la cantidad de un compuesto que modula positiva o negativamente el tipo específico de marcador de la salud de órganos o al ajustar la dieta del animal para reducir la cantidad de un compuesto que modula positiva o negativamente el tipo específico de marcador de la salud de órganos. El tipo específico de marcador de la salud de órganos puede ser uno o más de fósforo, fosfatasa alcalina, aspartato aminotransferasa o gamma-glutamiltransferasa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662434542P | 2016-12-15 | 2016-12-15 | |
PCT/IB2017/057852 WO2018109668A1 (en) | 2016-12-15 | 2017-12-12 | Compositions and methods that modulate phosphorus or enzymes in a companion animal |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018015452A true MX2018015452A (es) | 2020-02-10 |
Family
ID=60953909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018015452A MX2018015452A (es) | 2016-12-15 | 2017-12-12 | Composiciones y metodos que modulan fosforo o las enzimas en un aminal de compañia. |
Country Status (11)
Country | Link |
---|---|
US (1) | US11758928B2 (es) |
EP (1) | EP3554258B1 (es) |
JP (1) | JP2020501503A (es) |
CN (1) | CN109328018A (es) |
AU (1) | AU2017376922B2 (es) |
BR (1) | BR112018076326B1 (es) |
CA (1) | CA3025173A1 (es) |
ES (1) | ES2954279T3 (es) |
MX (1) | MX2018015452A (es) |
RU (1) | RU2763297C2 (es) |
WO (1) | WO2018109668A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018109667A1 (en) * | 2016-12-15 | 2018-06-21 | Nestec Sa | Compositions and methods that modulate white blood cells or neutrophils in a companion animal |
ES2952838T3 (es) * | 2016-12-15 | 2023-11-06 | Nestle Sa | Composiciones y métodos que modulan el colesterol en un animal de compañía |
KR102633086B1 (ko) * | 2018-11-12 | 2024-02-05 | 씨제이제일제당 주식회사 | N-아세틸-l-트립토판을 유효성분으로 포함하는 젖소용 사료첨가제 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1058686B1 (en) | 1998-02-25 | 2006-11-02 | Emory University | 2'-fluoronucleosides |
US7138103B2 (en) | 1998-06-22 | 2006-11-21 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
US8187624B1 (en) * | 2000-06-14 | 2012-05-29 | Kao Corporation | Compositions for taking dietary fibers |
EP1444326A4 (en) | 2001-08-24 | 2006-06-28 | Advanced Cell Tech Inc | SCREENING ASSAYS FOR IDENTIFICATION OF AGENTS INDUCING DIFFERENTIATION, AND PRODUCTION OF CELLS DIFFERENTIATED FOR CELL THERAPY |
ES2235642B2 (es) | 2003-12-18 | 2006-03-01 | Gat Formulation Gmbh | Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos. |
US20050266051A1 (en) | 2004-05-27 | 2005-12-01 | The Procter & Gamble Company | Pet food compositions and methods |
US7371401B2 (en) * | 2004-09-16 | 2008-05-13 | Land O'lakes Purina Feed Llc | Animal feed with a soluble fiber and sugar alcohol and method of making and method of feeding |
GB0423139D0 (en) | 2004-10-18 | 2004-11-17 | Danisco | Enzymes |
CA2581061C (en) | 2004-10-28 | 2014-09-02 | Lpath Therapeutics, Inc. | Compositions and methods for the treatment and prevention of hyperproliferative diseases |
TWI522337B (zh) | 2005-06-22 | 2016-02-21 | 普雷辛肯公司 | 用於激酶調節的化合物及方法及其適應症 |
KR101380190B1 (ko) | 2005-07-29 | 2014-04-11 | 콘서트 파마슈티컬즈, 인크. | 벤조 〔d〕〔1,3〕―디옥솔 유도체 |
US7704990B2 (en) | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
CA2622494A1 (en) | 2005-09-27 | 2007-04-05 | Irm Llc | Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
US20070110880A1 (en) * | 2005-11-01 | 2007-05-17 | Serenegy, Llc | Hypoallergenic animal food |
AR057623A1 (es) | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
ES2604656T3 (es) | 2006-02-28 | 2017-03-08 | Nestec S.A. | Composiciones y métodos para inducir crecimiento óseo e inhibir pérdida ósea |
CN101410713A (zh) | 2006-03-27 | 2009-04-15 | 希尔氏宠物营养品公司 | 用于预测动物中草酸盐结石和鸟粪石形成的方法 |
US7829674B2 (en) | 2006-10-27 | 2010-11-09 | Lpath, Inc. | Compositions and methods for binding sphingosine-1-phosphate |
KR20100031528A (ko) | 2007-06-01 | 2010-03-22 | 더 트러스티즈 오브 프린스턴 유니버시티 | 숙주세포 대사경로의 조절을 통한 바이러스 감염 치료 |
US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
CN102281768A (zh) | 2009-01-16 | 2011-12-14 | 希尔氏宠物营养品公司 | 包含丙酮酸及其盐的陪伴动物组合物及其使用方法 |
RU2485800C1 (ru) * | 2009-07-21 | 2013-06-27 | Хилл'С Пет Ньютришн, Инк. | Система для кормления домашнего животного |
WO2011069227A1 (en) | 2009-12-09 | 2011-06-16 | Best Environmental Technologies Inc. | Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
WO2011082106A1 (en) | 2009-12-29 | 2011-07-07 | Hill's Pet Nutrition, Inc. | Compositions including ginger for the amelioration or prevention of inflammatory conditions |
JP2012080830A (ja) | 2010-10-12 | 2012-04-26 | Mitsubishi Chemical Medience Corp | ヒト非アルコール性脂肪性肝炎(nash)の非ヒトモデル動物 |
AU2011345226B2 (en) | 2010-12-23 | 2014-11-13 | Hill's Pet Nutrition, Inc. | Pet food compositions and methods for treating arthritis and inflammation associated with arthritis |
ES2532378T3 (es) | 2011-01-20 | 2015-03-26 | The Procter & Gamble Company | Proceso para fabricar alimento para mascotas |
JP6013712B2 (ja) | 2011-09-06 | 2016-10-25 | 合同会社希少糖食品 | D−プシコースを有効成分とする生体代謝パラメーター改善剤 |
CN103987272B (zh) | 2011-12-19 | 2016-08-24 | 希尔氏宠物营养品公司 | 用于改善粪便质量的高度可消化的宠物食物 |
US20160000737A1 (en) * | 2013-03-15 | 2016-01-07 | Nusirt Sciences, Inc. | Treatment of pets with sirtuin activators |
-
2017
- 2017-12-12 RU RU2018146109A patent/RU2763297C2/ru active
- 2017-12-12 WO PCT/IB2017/057852 patent/WO2018109668A1/en unknown
- 2017-12-12 CN CN201780039496.5A patent/CN109328018A/zh active Pending
- 2017-12-12 EP EP17826564.1A patent/EP3554258B1/en active Active
- 2017-12-12 MX MX2018015452A patent/MX2018015452A/es unknown
- 2017-12-12 CA CA3025173A patent/CA3025173A1/en active Pending
- 2017-12-12 AU AU2017376922A patent/AU2017376922B2/en active Active
- 2017-12-12 BR BR112018076326-8A patent/BR112018076326B1/pt active IP Right Grant
- 2017-12-12 US US15/839,347 patent/US11758928B2/en active Active
- 2017-12-12 ES ES17826564T patent/ES2954279T3/es active Active
- 2017-12-12 JP JP2018562000A patent/JP2020501503A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112018076326B1 (pt) | 2023-03-07 |
RU2018146109A3 (es) | 2021-07-05 |
BR112018076326A2 (pt) | 2019-03-26 |
CA3025173A1 (en) | 2018-06-21 |
CN109328018A (zh) | 2019-02-12 |
EP3554258A1 (en) | 2019-10-23 |
ES2954279T3 (es) | 2023-11-21 |
EP3554258B1 (en) | 2023-07-19 |
AU2017376922A1 (en) | 2018-12-06 |
JP2020501503A (ja) | 2020-01-23 |
RU2763297C2 (ru) | 2021-12-28 |
AU2017376922B2 (en) | 2022-12-01 |
US20180168194A1 (en) | 2018-06-21 |
US11758928B2 (en) | 2023-09-19 |
RU2018146109A (ru) | 2020-06-25 |
WO2018109668A1 (en) | 2018-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018008553A (es) | Composiciones que contienen alquil poliurea hidroxilo funcional. | |
MX2022012374A (es) | Composiciones multi-suplementos. | |
PH12015502216A1 (en) | Compositions and methods for improving the health of aquatic animals | |
MX2017016819A (es) | Composiciones antimicrobianas y sus usos. | |
MX360847B (es) | Prevencion o retardo de respuesta al daño por enfriamiento en plantas. | |
MX2018015452A (es) | Composiciones y metodos que modulan fosforo o las enzimas en un aminal de compañia. | |
MX2018015451A (es) | Composiciones y metodos que modulan la digestibilidad en un animal de compañia. | |
MX2017013638A (es) | Composiciones de dentifrico con bajo contenido de agua. | |
AU2018276117A1 (en) | Animal feed supplement | |
MX2017003944A (es) | Combinacion de un acido graso omega-3 y un inhibidor de sglt-2 para tratar enfermedades hepaticas. | |
MX2017012850A (es) | Composicion absorbente de agua. | |
MX2018015344A (es) | Composiciones y metodos que modulan las bacterias en un animal de compañía. | |
MX2017008450A (es) | Composiciones inhibidoras de nitrificacion microencapsuladas. | |
MX2018013184A (es) | Composiciones de saponinas y extractos vegetales. | |
PH12017500971A1 (en) | Synergistic bacterial consortia for mobilizing soil phosphorus | |
MX2015015127A (es) | Enzimas para alimentacion animal. | |
PH12017500357A1 (en) | Lactic acid bacteria-containing composition | |
PH12016502386A1 (en) | Oral care compositions | |
MX2017000454A (es) | Composiciones bucales antisarro. | |
EP3709808A4 (en) | COMPOSITIONS AND METHODS FOR IMPROVING THE USE OF DIETARY PHOSPHORUS AND CALCIUM IN ANIMALS | |
SG10201808326QA (en) | Nutrition composition | |
MX2018007468A (es) | Composiciones de colageno 7 y metodos para usar las mismas. | |
EA202190622A1 (ru) | Композиция для эрадикации helicobacter pylori | |
SG11201903370SA (en) | Allulose-containing composition for promoting excretion of vegetable lipids from the body | |
MX2016014587A (es) | Productos alimenticios a base de almendra con caracteristicas de sabor mejoradas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. |